Home › Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520
 

Keywords :   


Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520

2014-06-14 04:22:56| Biotech - Topix.net

Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today reaffirmed its belief that it has broad access to intellectual property required to develop ARC-520, its clinical candidate against chronic hepatitis B infection.

Tags: issues statement property protection

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Bolt drivers win right to holiday and minimum wage
08.11INX details acquisition, SpectraGraphics grows and more
08.11Axalta Celebrates the Opening of its Global Headquarters in the Philadelphia Navy Yard
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 21
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11BW Converting assists SunDance with flexible packaging pivot
08.11Sheboygan Paint Company Names New Regional Sales Managers
More »